University of Maryland School of Medicine
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Brandler, Brian
NCT04210713: Neuroimmune Dysfunction in Alcohol Use Disorder

Completed
1
142
US
Minocycline, Sugar pill, Placebo
University of Maryland, Baltimore, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Drinking, Alcohol-Related Disorders, Disease, Inflammation, Alcoholism, Cognitive Dysfunction, Pathologic Processes, Drinking Behavior, Substance-Related Disorders, Chemically-Induced Disorders, Mental Disorder, Cognition Disorder, Neurocognitive Disorders, Minocycline, Anti-Bacterial Agents, Anti-Infective Agents
09/23
09/23
DKMOI, NCT06029296: Diclofenac as a KMO Inhibitor

Recruiting
1
12
US
Diclofenac, Placebo
University of Maryland, Baltimore
Alcohol Use Disorder
06/25
06/25
NCT06583239: Hub-Based Engagement Navigator Service to Reduce CSC Disengagement

Not yet recruiting
N/A
555
US
Engagement Navigator Service (ENS)
University of Maryland, Baltimore
Disengagement
07/29
07/29

Download Options